Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Changing the timing of cancer vaccines

24.01.2005


A molecule specially modified by researchers at Baylor College of Medicine can reset the biological clock for cancer vaccines, potentially making them more potent.



In a report that appears online today in Nature Medicine, Dr. David Spencer and colleagues describe their method of delaying the time at which crucial dendritic cells are activated by the immune system. This prolongs the time during which the cancer vaccines can undertake their task, he said.

Dendritic cells are important because they present to the immune system the proteins or antigens that cause the immune system to go into action. They are key to cancer vaccines that seek to alert the immune system to presence of cancer by making it aware of tumor antigens or proteins that are unique to that malignancy.


"Once you activate dendritic cells, you turn on a biological clock," said Spencer, an associate professor of immunology at BCM. "Dendritic cells have a finite life span after they are activated."

The makers of cancer vaccines would like to activate the dendritic cells, expose them to the tumor antigens and then reinject them into patients. Once in the body, they would migrate to the lymph nodes where they interact with specific immune system operatives called T-cells, activating them to attack the cancer. However, the process can take as long as a day, reducing the period during which the dendritic cells are active and can accomplish their work.

However, using a drug that results in the linking of two identical molecules (a process called dimerization), Spencer and colleagues found that they could wait until the dendritic cells got to the lymph nodes to activate them. That significantly extends the period during which the cells can remain active and, in turn, activate the immune system’s T-cells.

Spencer steered graduate student Brent Hanks toward manipulating dendritic cells, but credits Hanks with settling upon a molecule called CD40 that could be used to activate the dendritic cells after they reached the lymph nodes.

"This was a key decision, since CD40 is likely the most potent activation molecule on these cells," he said. "Our dendritic cells live longer in the lymph nodes and we think they are more potent when the get there."

"We think because of the special attributes of this approach, it should have a better chance of working in patients whose immune systems are already attenuated by disease or prior treatment and should be complementary to other approaches already out there," said Spencer.

Others who participated included Drs. Kevin M. Slawin, Rana A K Singh, Michael Barry, Jianghong Jiang, and Weitao Song, all of BCM.

Ross Tomlin | EurekAlert!
Further information:
http://www.bcm.tmc.edu

More articles from Health and Medicine:

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht On track to heal leukaemia
18.01.2017 | Universitätsspital Bern

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

New Study Will Help Find the Best Locations for Thermal Power Stations in Iceland

19.01.2017 | Earth Sciences

Not of Divided Mind

19.01.2017 | Life Sciences

Molecule flash mob

19.01.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>